Day 0 after injection
|
Absolute VAS change, median (IQR)
|
−26.8 (–54.8 to –14.3)
|
−56.7 (–73.3 to –28.6)
|
−36.0 (–72.3 to –14.3)
|
0.22
|
50 % reduction in sciatica pain, n (%)
|
5 (27.8)
|
9 (52.9)
|
14 (40.0)
|
0.13
|
PASS <40 mm, n (%)
|
5 (27.8)
|
12 (70.6)
|
17 (48.6)
|
0.01*
|
MCII ≥15 mm, n (%)
|
12 (66.7)
|
13 (76.5)
|
25 (71.4)
|
0.52
|
MCII ≥20 %, n (%)
|
11 (61.1)
|
13 (76.5)
|
24 (68.6)
|
0.33
|
Day 10 after injection
|
Absolute VAS change, median (IQR)
|
−14.9 (–50.0 to 3.3)
|
0.0 (–30.9 to 10.0)
|
−9.2 (–38.5 to 9.1)
|
0.21
|
50 % reduction in sciatica pain, n (%)
|
5 (27.8)
|
3 (17.6)
|
8 (22.9)
|
0.69
|
PASS <40 mm, n (%)
|
4 (22.2)
|
4 (23.5)
|
8 (22.9)
|
0.94
|
MCII ≥15 mm, n (%)
|
9 (50.0)
|
5 (29.4)
|
14 (40.0)
|
0.21
|
MCII ≥20 %, n (%)
|
8 (44.4)
|
5 (29.4)
|
13 (37.1)
|
0.36
|